Nanalysis Scientific Corp. ( OTCQX:NSCIF ) Q4 2024 Earnings Conference Call April 24, 2025 5:00 PM ET Company Participants Matthew Selinger - Investor Relations Sean Krakiwsky - Founder and CEO Randall McRae - Chief Financial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen. And welcome to the Nanalysis Q4 and Full Year 2024 Conference Call.
At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Thursday, April 24, 2025.
I would now like to turn the conference over to Mr. Matthew Selinger from Investor Relations. Thank you.
Please go ahead. Matthew Selinger Thank you, Operator, and welcome, everyone, to the Nanalysis Scientific’s fourth quarter and full year 2024 conference call. Before we begin, I would like to remind everyone that remarks and responses to your questions today will contain forward-looking statements that are based on the current expectations of management.
These assumptions involve inherent risks and uncertainties that could cause actual results to differ materially from our responses. Certain material factors and assumptions were considered and applied in making the forward-looking statements. These risk factors are included in our filings for the year ended December 31, 2024.
Forward-looking statements on this call may include, but are not limited to, statements and comments with respect to future growth of the company’s business, the ability to graduate to a senior exchange, the company’s acquisition strategy, the ability to develop future products, and the possible associated results. The company’s actual performance and financial results in the future could differ materially from any estimates or projections of future performance implied by the forward-looking statements. The forward-looking statements made on this call speak only as of today, and Nanalysis Scientific assumes no obligation to update any such forward-looking information as.